Covid-19 ImageSymbol: OTCQB:XPHYF

OTCQB:XPHYF is involved with what could be a POWERFUL tool in the COVID arsenal.

Point of Care COVID 19 Rapid Diagnostic testThis TRI-LISTED BioTech Stock in the US, Canada, and Germany, also has its hands in some of the most cutting-edge industries today from CBD, THC, and even Psychedelics!

XPhyto Therapeutics Corp. (XPHYF) is a Bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids.

And now the company had MAJOR BREAKING NEWS out yesterday that could certainly turn heads on the Street...

Subscribe to Receive Client Updates Delivered Straight To Your Inbox

Recent News

Emerging Markets Report

Must Read OTC Markets/SEC policy on stock promotion and investor protection


Emerging Markets is under contract to be paid 150,000 dollars by XPhyto Therapeutics Corp. | Please read our full disclaimer